Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PETMED EXPRESS INC Director's Dealing 2021

Jun 4, 2021

34556_dirs_2021-06-04_cd31d0db-6bd9-414c-9650-ea013973a971.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PETMED EXPRESS INC (PETS)
CIK: 0001040130
Period of Report: 2021-06-02

Reporting Person: ROSENBLOOM BRUCE S (CFO & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-02 Common Stock S 6000 $42.50 Disposed 30525 Direct

Footnotes

F1: The reported transactions are pursuant to a pre-arranged structured sales plan, which was executed on February 18, 2021, that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.